Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Sparse whole genome sequencing and machine learning of AML genomes reveals novel, clinically relevant genetics.

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYanming ZhangMLMark R. LitzowNDNevenka Dimitrova

Discussion

Loading...

Member takes

Overview

Analysis reveals novel prognostic model and risk stratification in acute myeloid leukemia, indicating advanced machine learning applications.

Key Points

  • Machine learning applied to whole genome sequencing uncovers genetic alterations affecting survival in AML.
  • A prognostic model highlights inferior outcomes in patients with specific chromosomal alterations.
  • Non-negative Matrix Factorization identifies cryptic information missed by traditional methods in AML genetics.
  • Results underscore the potential for enhanced risk stratification and clinical management of myeloid neoplasms.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/69362f6c4fa91c937236e047https://doi.org/10.1182/blood-2025-5263
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sensitive detection of novel structural variants and 3D chromosome conformation reveals likely novel drivers including enhancer hijacking in AML2025
  2. 2Rapid and Reproducible Karyotyping with Long Read Sequencing in AML Patients2026
  3. 3Integrative Genomic and Immune Profiling to Identify and Characterize High-Risk Subgroups in Acute Myeloid Leukemia: Development of a 20-Gene Predictive Signature and Its Clinical Implications.2025 · 2 citations
  4. 4Interim results of a multi-center clinical trial evaluating copy number aberrations via shallow whole-genome sequencing (LeukoPrint) in Acute Myeloid Leukemia2025
  5. 5Prognostic evaluation of ELN-2022 and ELN-2024 risk stratification in newly diagnosed AML patients and development of a novel genetic risk model2025